Prosecution Insights
Last updated: May 29, 2026

Foley Hoag, LLP (General)

149 pending office actions • 94 clients • 134 examiners • 81 art units • 0 of 149 (0%) have an AI response strategy ready • 209 patents granted in the last 365 days

Portfolio Summary

149
Total Pending OAs
99
Non-Final OAs
43
Final Rejections
7
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 147 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

103
Overdue
4
Due this week
22
Due this month
11
Due in next 60 days
7
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 147 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (103)Due ≤ 7 days (4)Due ≤ 30 days (22)Due ≤ 60 days (11)Due later (7)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

7
Hard (5%)
92
Medium (62%)
18
Easy (12%)
32
Unknown (21%)

Rejection Statute Mix

BucketCases
§101 only7 (5%)
§103 only83 (56%)
§102 only7 (5%)
§112 only18 (12%)
Double-patenting + other2 (1%)
No statute on record32 (21%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

107
Life Sciences
72% of docket
4
Information Tech
3% of docket
3
Communications
2% of docket
0
Semiconductors
0% of docket
35
Mechanical / Eng
23% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,490 h
Manual time on pending OAs
298 h
Time saved (low, 20%)
522 h
Time saved (mid, 35%)
13.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BUI, PHUONG T 3 81.6% +22.8%
TIEN, LUCY MINYU 3 61.3% +35.6%
LANE, DANIEL E 2 4.1% +8.6%
FAN, WEIHUA 2 83.0% +13.0%
JACKSON-TONGUE, LAKIA J 2 68.8% +20.4%
MARTIN, KEVIN STEPHEN 2 75.9% +23.6%
SULLIVAN, DENNIS JOHN 2 61.0% +49.9%
HIRAKIS, SOPHIA P 2 41.2% +74.1%
FAN, LYNN Y 2 46.6% +49.1%
JOHNSON, CHRISTOPHER LINDSAY 2 54.2% +73.3%

Quick Wins (5)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18132073 HYBRID PEPPER 'E20S.10382' BUI, PHUONG T 121d overdue
18196536 HYBRID TOMATO VARIETIES 'E15C42785' AND 'E15C42788' BUI, PHUONG T 30d overdue
18206368 LETTUCE VARIETIES 'EZFLOR', 'BAUER', AND 'ADICAMP' FAN, WEIHUA 23d overdue
18443705 INBRED SPINACHES 'OS0692', 'OS0694', AND 'OS0699' FAN, WEIHUA 56d
18436462 HYBRID TOMATO VARIETY 'E15M43069', 'E15T43094' and 'E15T43096' BUI, PHUONG T

Hard Cases (9)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18348128 MAD NUCLEASES REGLAS, GEORGIANA C 91d overdue
17936708 COMPUTATIONAL APPROACHES TO ASSESSING CENTRAL NERVOUS SYSTEM FUNCTIONALITY USING A DIGITAL TABLET AND STYLUS GRANT, MICHAEL CHRISTOPHER 72d overdue
17324366 OFFER SELECTION OPTIMIZATION FOR PERSONA SEGMENTS MPAMUGO, CHINYERE 60d overdue
18774469 METHOD FOR DETECTING IMPAIRMENT STATUS ON INSTRUMENTAL ACTIVITIES OF DAILY LIVING LANE, DANIEL E 50d overdue
18768458 SYSTEMS AND METHODS FOR PREDICTING PET AMYLOID BIOMARKER STATUS USING MULTIMODAL DIGITAL COGNITIVE ASSESSMENTS LANE, DANIEL E 50d overdue
18596170 TECHNIQUES FOR REAL-TIME RESPONSE STRATEGIES IN A SUPPLY CHAIN EL-BATHY, IBRAHIM N 31d overdue
18223833 HYBRID TOMATO VARIETIES 'E15A51293' AND 'E15A51296' DEVEAU ROSEN, JASON 31d overdue
18647916 PREDICTIVE RFM SEGMENTATION EL-HAGE HASSAN, ABDALLAH A 5d

Interview Candidates (20)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18132073 HYBRID PEPPER 'E20S.10382' BUI, PHUONG T 121d overdue
18285890 PHARMACEUTICAL COMPOSITION CONTAINING BACTERIA JACKSON-TONGUE, LAKIA J 99d overdue
17920226 TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS JOHNSON, CHRISTOPHER LINDSAY 96d overdue
18035399 VISTA AGONIST FOR TREATMENT/PREVENTION OF ISCHEMIC AND/OR REPERFUSION INJURY SULLIVAN, DENNIS JOHN 37d overdue
17779002 METHODS OF TREATING CANCER USING DKK-1 INHIBITORS SULLIVAN, DENNIS JOHN 37d overdue
18018207 ARYL SUBSTITUTED PYRROLO-PYRIDINONES AND THERAPEUTIC USES THEREOF MARTIN, KEVIN STEPHEN 31d overdue
18196536 HYBRID TOMATO VARIETIES 'E15C42785' AND 'E15C42788' BUI, PHUONG T 30d overdue
18032067 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER HIRAKIS, SOPHIA P 30d overdue

Client Portfolio (94 clients)

Client (Assignee)Pending OAs
Enza Zaden 10
Evelo Biosciences 6
Linus Health 5
Punchh Inc. 4
Technische Universität München 4
Bolton Medical 4
Inscripta 4
THE GENERAL HOSPITAL CORPORATION 4
Amazentis 3
TPI Composites 3
VASCUTEK LIMITED 3
DiscGenics, Inc. 3
STEALTH BIOTHERAPEUTICS INC. 3
THE UNIVERSITY OF BIRMINGHAM 3
Lenbrook Industries 2
ConnectWise, LLC 2
Quantum-Si Incorporated 2
Cognosos 2
BioCryst Pharmaceuticals, Inc 2
University of Illinois 2
University of Colorado 2
BAYER AKTIENGESELLSCHAFT 2
Navtrix Pty Ltd 2
Leap Therapeutics 2
Simsi, Inc. 1
Arkea Bio 1
SPINTHYR TECHNOLOGIES, LLC 1
NATIONAL UNIVERSITY OF SINGAPORE 1
Backbar Solutions 1
NeoPhore Limited 1
CareTech Human Inc. 1
Imaginatives Group Limited 1
Dr. Reddy's 1
Revelation Biosciences, Inc. 1
Nutrition21, LLC 1
Lawell Therapeutics 1
Kneevoice, Inc. 1
ONCOCUBE THERAPEUTICS LLC 1
PRIME MEDICINE, INC. 1
Celleron Therapeutics Limited 1
Pattent, LLC 1
Cellino Biotech 1
THE UNIVERSITY OF MANCHESTER 1
THE UNIVERSITY OF LIVERPOOL 1
Odyssey Therapeutics UK Limited 1
EPFL 1
Tabomedex Biosciences, Inc. 1
REPAIR BIOTECHNOLOGIES, INC. 1
Columbia University 1
Jnana Therapeutics 1
Centro de Inmunología Molecular 1
ZBiotics 1
University of Limpopo 1
Dartmouth College 1
Applied Cavitation, Inc. 1
AOA Dx 1
Hai Kang Life 1
Spd Swiss Precision Diagnostics GmbH 1
UNIVERSITY OF OXFORD 1
RF Labs, Inc. 1
IPEX USA LLC 1
DANA-FARBER CANCER INSTITUTE, INC. 1
Hansoh Pharmaceutical 1
Commonwealth Scientific and Industrial Research Organisation 1
Anaxis Pharma Pty Ltd 1
AHS Hospital 1
GenoFocus, Inc. 1
C4X Discovery 1
Roslin Technologies Limited 1
Real Isolates, LLC 1
United Biomedical, Inc. 1
Spareit, Inc. 1
IntoCell, Inc. 1
University of South Africa 1
University of Nebraska 1
Quantum Diamond Technologies Inc. 1
GNT Pharma 1
MEDIZINISCHE HOCHSCHULE HANNOVER 1
DIONIS THERAPEUTICS, INC. 1
Anaphite 1
Michael S. Clemmons 1
SeraCare Life Sciences, Inc. 1
Y-Biologics, Inc. 1
PrevEp, Inc. 1
2seventy bio 1
Advantage Therapeutics 1
Crt Pioneer Fund LP 1
Sapphiros Al Bio LLC 1
Boyce Thompson Institute for Plant Research 1
Verseau Therapeutics, Inc. 1
Williwaw Biosciences LLC 1
BIOSCEPTRE (UK) LIMITED 1
Orig3n, Inc. 1
Atara Biotherapeutics 1

Top Art Units

Art UnitApps
16637
37154
37914
16244
16124
16454
16254
16914
16283
37713

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19170782 ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS Amazentis SA VALENROD, YEVGENY 1628 §103 Non-Final OA 55d Pending Apr 04, 2025
19170838 METHODS FOR AUTOMATING THE PROMPTING AND POST-PROCESSING OF AI SYSTEMS FOR INTERPRETATION AND REPORTING OF PUBLIC SAFETY DATA, STATISTICS, AND CONTEXTUAL KNOWLEDGE Simsi, Inc. PADUA, NICO LAUREN 3626 §103 Non-Final OA 11d overdue Pending Apr 04, 2025
19049535 POWER OVER ETHERNET (PoE) POWERED SMART SPEAKER Lenbrook Industries Limited PAUL, DISLER 2695 §103 Final Rejection 11d overdue Pending Feb 10, 2025
19028700 ROOT INSERT STOPPER FASTENING EQUIPMENT Tpi Technology, Inc. COOK, KYLE A 3726 §112 Non-Final OA 46d overdue Pending Jan 17, 2025
18977008 VACCINES COMPRISING METHANOBREVIBACTER GOTTSCHALKII Arkea Bio Corp. FOLEY, SHANON A 1671 §102 Non-Final OA 264d overdue Pending Dec 11, 2024
18933600 CENTRALIZED CLOUD SERVICE MANAGEMENT Connectwise, LLC ALMANI, MOHSEN 2159 §103 Non-Final OA 17d overdue Pending Oct 31, 2024
18861976 CHEST BOLT AND THORACOSTOMY BOLT Spinthyr Technologies, LLC LONG, SARAH A 3771 §103 Non-Final OA 28d overdue Pending Oct 31, 2024
18926860 STENT DEVICE VASCUTEK LIMITED RIVERS, LINDSEY RAE 3771 Other Non-Final OA 25d overdue Pending Oct 25, 2024
18842526 SPINACH PLANT RESISTANT TO DOWNY MILDEW AND NOVEL RESISTANCE GENE Enza Zaden Beheer B.V. ORDAZ, CHRISTIAN JOSE 1663 §112 Non-Final OA 26d Pending Aug 29, 2024
18809761 WATERMELON VARIETY ‘E26C00199’ Enza Zaden Beheer B.V. BOGGS, RUSSELL T 1663 §112 Non-Final OA 62d Pending Aug 20, 2024
18805772 SPATIAL COORDINATE TRACKING OF WIND TURBINE ASSEMBLY COMPONENTS USING LASER PROJECTION SYSTEM Tpi Composites, Inc. SONG, INJA 1744 §102 Non-Final OA 50d overdue Pending Aug 15, 2024
18792939 GENERALIZED ENTERPRISE CATALOG CLASSIFICATION FOR SHORTHAND ITEMDESCRIPTORS Punchh Inc. FRUNZI, VICTORIA E. 3689 §101 Non-Final OA 26d Pending Aug 02, 2024
18790836 EXTENSIBILITY NETWORKING LAYER OF AN INTEGRATION SYSTEM Connectwise, LLC NGUYEN, HAO HONG 2447 §103 Non-Final OA 70d Pending Jul 31, 2024
18783046 LETTUCE VARIETY 'SUNBERG’ Enza Zaden Beheer B.V. ZHONG, WAYNESHAOBIN 1662 §112 Non-Final OA 65d Pending Jul 24, 2024
18778356 LETTUCE VARIETY 'E01G11679' Enza Zaden Beheer B.V. BYRNES, DAVID R 1662 §112 Non-Final OA 38d overdue Pending Jul 19, 2024
18774469 METHOD FOR DETECTING IMPAIRMENT STATUS ON INSTRUMENTAL ACTIVITIES OF DAILY LIVING Linus Health, Inc. LANE, DANIEL E 3715 §103 Final Rejection 50d overdue Pending Jul 16, 2024
18768458 SYSTEMS AND METHODS FOR PREDICTING PET AMYLOID BIOMARKER STATUS USING MULTIMODAL DIGITAL COGNITIVE ASSESSMENTS Linus Health, Inc. LANE, DANIEL E 3715 §103 Final Rejection 50d overdue Pending Jul 10, 2024
18670099 PERISTALTIC PUMPING OF FLUIDS AND ASSOCIATED METHODS, SYSTEMS, AND DEVICES Quantum-Si Incorporated KASTURE, DNYANESH G 3746 §103 Non-Final OA 15d overdue Pending May 21, 2024
18647916 PREDICTIVE RFM SEGMENTATION Punchh Inc. EL-HAGE HASSAN, ABDALLAH A 3623 §101 Final Rejection 5d Pending Apr 26, 2024
18627964 SYSTEMS AND METHODS FOR MOBILE SPEECH HEARING OPTIMIZATION Linus Health, Inc. ROBERTS, ANNA L 3791 §103 Non-Final OA 4d overdue Pending Apr 05, 2024
18603163 POLYMERIZING ENZYMES FOR SEQUENCING REACTIONS Quantum-Si Incorporated EPSTEIN, TODD MATTHEW 1652 Other Non-Final OA 71d overdue Pending Mar 12, 2024
18690537 POLYSACCHARIDE OR POLYSACCHARIDE MIXTURE PRODUCED BY PAENIBACILLUS POLYMYXA Technische Universität München LANKFORD JR, LEON B 1657 §103 Non-Final OA 8d overdue Pending Mar 08, 2024
18596170 TECHNIQUES FOR REAL-TIME RESPONSE STRATEGIES IN A SUPPLY CHAIN Cognosos, Inc. EL-BATHY, IBRAHIM N 3628 §101 Non-Final OA 31d overdue Pending Mar 05, 2024
18443705 INBRED SPINACHES 'OS0692', 'OS0694', AND 'OS0699' Enza Zaden Beheer B.V. FAN, WEIHUA 1663 §112 Non-Final OA 56d Pending Feb 16, 2024
18682544 WOUND MONITORING SYSTEM AND SENSOR THEREOF National University Of Singapore WESTFALL, SARAH ANN 3791 §103 Non-Final OA 26d Pending Feb 09, 2024
18436462 HYBRID TOMATO VARIETY 'E15M43069', 'E15T43094' and 'E15T43096' Enza Zaden Beheer B.V. BUI, PHUONG T 1663 §103 Final Rejection Pending Feb 08, 2024
18431448 PARAMETRIC AND AUTOMATED TOOL FOR THE DESIGN OF STEEL SUBSTRUCTURE OF COMPOSITE MOLDS Tpi Technology, Inc. ARTHUR JEANGLAUDE, GERTRUDE 3661 §103 Non-Final OA 9d Pending Feb 02, 2024
18416244 ISOLATED DISCOGENIC CELLS, METHODS OF USING, AND METHODS OF PREPARING SAME FROM MAMMALIAN TISSUE Discgenics, Inc. PAPCIAK, SHARON M 1657 Other Final Rejection 30d overdue Pending Jan 18, 2024
18407053 SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS Biocryst Pharmaceuticals, Inc. O DELL, DAVID K 1621 Final Rejection 171d overdue Pending Jan 08, 2024
18405347 RESTORING PHYSIOLOGY WITH SMALL MOLECULE MIMICS OF MISSING PROTEINS The Board Of Trustees Of The University Of Illinois OLSON, ANDREA STEFFEL 1693 Other Non-Final OA 113d overdue Pending Jan 05, 2024
18575007 SYSTEM AND METHOD FOR CONTACTLESS DRINK DISPENSING Backbar Solutions PANCHOLI, VISHAL J 3754 §103 Non-Final OA 32d overdue Pending Dec 28, 2023
18570244 INHIBITOR COMPOUNDS Neophore Limited NESTOR, DONNA MICHELLE 1627 Other Non-Final OA 15d overdue Pending Dec 14, 2023
18538877 IDENTIFICATION OF A PERSON BY THE UNIQUE CHEMICAL COMPOSITION OF A BIOMATERIAL IN DIFFERENT PHASES Caretech Human Inc. ABOUELELA, MAY A 3791 §103 Non-Final OA 3d overdue Pending Dec 13, 2023
18565721 MINERALOCORTICOID RECEPTOR ANTAGONISTS FOR THE PREVENTION AND/OR TREATMENT OF A CORONAVIRUS INFECTION Imaginatives Group Limited BARSKY, JARED 1628 §103 Non-Final OA 23d overdue Pending Nov 30, 2023
18564384 CANCER THERAPY USING A COMBINATION OF CDK7 INHIBITOR WITH AN ANTI-CANCER AGENT Aurigene Discovery Technologies Limited ROMERO, KRISTEN WANG 1624 Other Non-Final OA 8d overdue Pending Nov 27, 2023
18562719 MPLA COMPOSITIONS AND METHODS OF USE Revelation Biosciences, Inc. TIEN, LUCY MINYU 1612 Other Non-Final OA 17d overdue Pending Nov 20, 2023
18511413 CHROMIUM CONTAINING COMPOSITIONS FOR IMPROVING HEALTH AND FITNESS Nutrition21, LLC CHEN, CATHERYNE 1655 §103 Non-Final OA 19d overdue Pending Nov 16, 2023
18503569 AORTIC PROSTHESIS DELIVERY DEVICE AND METHOD OF USE Bolton Medical, Inc. BARIA, DINAH N 3774 §102 Non-Final OA 34d Pending Nov 07, 2023
18491049 DUAL STRAND NUCLEIC ACID-GUIDED NICKASE EDITING Inscripta, Inc. MONTANARI, DAVID A 1632 Other Non-Final OA 10d overdue Pending Oct 20, 2023
18287784 METHODS OF PREPARING AN EXTRACORPOREAL CIRCUIT FOR ANTICOAGULATION Lawell Therapeutics, LLC DEAK, LESLIE R 3799 §102 Non-Final OA 3d overdue Pending Oct 20, 2023
18381910 ASSESSING JOINT CONDITION USING ACOUSTIC SENSORS Kneevoice, Inc. FERNANDES, PATRICK M 3791 Other Non-Final OA 19d overdue Pending Oct 19, 2023
18286469 COMPOSITIONS AND METHODS FOR TREATING CANCER Oncocube Therapeutics LLC VALLE, ERNESTO 1623 Other Non-Final OA 34d Pending Oct 11, 2023
18285890 PHARMACEUTICAL COMPOSITION CONTAINING BACTERIA Evelo Biosciences, Inc. JACKSON-TONGUE, LAKIA J 1645 §102 Non-Final OA 99d overdue Pending Oct 06, 2023
18285570 SILICA-BASED FORMULATIONS OF THERAPEUTIC OLIOGPEPTIDES AND PEPTIDOMIMETICS Stealth BioTherapeutics Inc. TIEN, LUCY MINYU 1612 Other Non-Final OA 7d Pending Oct 04, 2023
18478179 METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES Prime Medicine, Inc. MCKNIGHT, CIARA A 1656 §103 Non-Final OA 89d overdue Pending Sep 29, 2023
18374250 CONTEXTUAL AWARENESS FOR UNSUPERVISED ADMINISTRATION OF COGNITIVE ASSESSMENTS REMOTELY OR IN A CLINICAL SETTING Linus Health, Inc. WEBB, JESSICA MARIE 3683 §103 Final Rejection 15d Pending Sep 28, 2023
18283158 VACCINE ADJUVANT Celleron Therapeutics Limited OH, TAYLOR V 1625 §103 Non-Final OA 60d overdue Pending Sep 20, 2023
18243072 SYSTEM AND METHOD FOR DETERMINING A ROUTE OF AN UNMANNED AERIAL SYSTEM Pattent, LLC LEE, BRANDON DONGPA 3662 Non-Final OA 170d overdue Pending Sep 06, 2023
18240550 METHODS FOR INCREASED NUCLEIC ACID-GUIDED CELL EDITING Inscripta, Inc. BRETZ, COREY LANE 1635 §103 Non-Final OA 3d overdue Pending Aug 31, 2023
18238261 COMPOSITIONS AND METHODS FOR TREATING TYPE 2 DIABETES USING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) The Regents of the University of Colorado LEE, JIA-HAI 1658 DPOther Non-Final OA 75d Pending Aug 25, 2023
18234345 SYSTEMS AND METHODS FOR CELL MANUFACTURING Cellino Biotech, Inc. EDWARDS, LYDIA E 1796 §103 Non-Final OA 27d Pending Aug 15, 2023
18223833 HYBRID TOMATO VARIETIES 'E15A51293' AND 'E15A51296' Enza Zaden Beheer B.V. DEVEAU ROSEN, JASON 1662 §101 Final Rejection 31d overdue Pending Jul 19, 2023
17926847 ANTIVIRAL POLYMERS The University of Manchester PIPIC, ALMA 1617 §103 Non-Final OA 25d overdue Pending Jul 19, 2023
18272697 AZAQUINAZOLINE DERIVATIVES FOR USE IN TREATING OR PREVENTING DIROFILARIA INFECTION IN A MAMMAL The University of Liverpool RAO, PADMAJA S 1627 Other Non-Final OA 28d Pending Jul 17, 2023
18271918 QUANTUM COMPUTING SYSTEM AND METHOD Odyssey Therapeutics UK Limited GOODCHILD, WILLIAM J 2433 §103 Non-Final OA 6d Pending Jul 12, 2023
18221140 MITOCHONDRIA-TARGETING PEPTIDES Stealth BioTherapeutics Inc. OTTON, ALICIA L 1699 §103 Non-Final OA 55d Pending Jul 12, 2023
18271503 PRODUCTS AND METHODS FOR PROMOTING MYOGENESIS ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE PAULUS, ERIN VIRGINIA 1631 §103 Non-Final OA 4d overdue Pending Jul 10, 2023
18348128 MAD NUCLEASES Inscripta, Inc. REGLAS, GEORGIANA C 1651 §101 Non-Final OA 91d overdue Pending Jul 06, 2023
18270616 FUSED QUADRACYCLIC COMPOUNDS, COMPOSITIONS AND USES THEREOF Tabomedex Biosciences, Inc. VISHNYAKOVA, ELENA VLADIMIROVNA 1691 §112 Non-Final OA 8d Pending Jun 30, 2023
18269869 HEPATOCELLULAR CARCINOMA TREATMENTS, PROPHYLACTIC THERAPIES, AND COMPOSITIONS FOR USE THEREWITH Repair Biotechnologies, Inc. IANNUZO, NATALIE NMN 1653 §103 Non-Final OA 50d overdue Pending Jun 27, 2023
18268688 DOSING REGIMENS FOR ORAL ALK2 KINASE INHIBITORS Biocryst Pharmaceuticals, Inc. HERNANDEZ, JACKSON J 1627 Other Final Rejection 56d Pending Jun 21, 2023
18210992 MACROPHAGES/MICROGLIA IN NEURO-INFLAMMATION ASSOCIATED WITH NEURODEGENERATIVE DISEASES The General Hospital Corporation MCANANY, JOHN D 1625 §103 Final Rejection 15d Pending Jun 16, 2023
18268102 METHODS OF TREATING NEURODEGENERATIVE DISORDERS AND STAT3-LINKED CANCERS USING SUPPRESSORS OF ELECTRON LEAK Cornell University MARTIN, KEVIN STEPHEN 1624 §103 Non-Final OA 6d Pending Jun 16, 2023
17769173 REACTIVE AFFINITY PROBE-INTERACTION DISCOVERY PLATFORM Jnana Therapeutics Inc. DAUNER, JOSEPH G 1682 §103 Non-Final OA 22d overdue Pending Jun 15, 2023
18266486 USE OF VACCINE COMPOSITIONS BASED ON SARS-COV-2 RECEPTOR BINDING DOMAIN IN DELIVERING PROTECTIVE IMMUNITY Centro De Inmunología Molecular CHEN, STACY BROWN 1672 §103 Non-Final OA 35d overdue Pending Jun 09, 2023
18206368 LETTUCE VARIETIES 'EZFLOR', 'BAUER', AND 'ADICAMP' Enza Zaden Beheer B.V. FAN, WEIHUA 1663 §112 Final Rejection 23d overdue Pending Jun 06, 2023
18202182 METHODS AND COMPOSITION FOR TREATING METABOLIC SYNDROME Zbiotics Company PRAKASH, SUBBALAKSHMI 1793 §103 Final Rejection 28d Pending May 25, 2023
18254120 METHODS AND SYSTEMS FOR TREATMENT OF INTERVERTEBRAL DISC BY INTRADISCAL MICRO-NEEDLE INSERTION Discgenics, Inc. BOSWORTH, KAMI A 3783 §103 Non-Final OA 28d Pending May 23, 2023
18037669 PRODUCTION OF ALKALI METAL CARBONATES AND/OR BICARBONATES FROM ALKALI METAL SULPHATES University of Limpopo SIMKINS, SLONE ELIZABETH 1735 §103 Final Rejection 21d Pending May 18, 2023
18196536 HYBRID TOMATO VARIETIES 'E15C42785' AND 'E15C42788' Enza Zaden Beheer B.V. BUI, PHUONG T 1663 §112 Final Rejection 30d overdue Pending May 12, 2023
18035399 VISTA AGONIST FOR TREATMENT/PREVENTION OF ISCHEMIC AND/OR REPERFUSION INJURY The Trustees of Dartmouth College SULLIVAN, DENNIS JOHN 1642 Other Non-Final OA 37d overdue Pending May 04, 2023
18034202 COMPOSITIONS COMPRISING SPIRULINA COMPONENTS Evelo Biosciences, Inc. ARIANI, KADE 1651 §103 Non-Final OA 29d Pending Apr 27, 2023
18032067 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER BAYER AKTIENGESELLSCHAFT HIRAKIS, SOPHIA P 1623 Other Non-Final OA 30d overdue Pending Apr 14, 2023
18032096 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER BAYER AKTIENGESELLSCHAFT HIRAKIS, SOPHIA P 1623 §112 Non-Final OA 30d overdue Pending Apr 14, 2023
18248922 SYSTEMS AND METHODS FOR PRODUCTION OF MATERIALS USED IN ADDITIVE MANUFACTURING Applied Cavitation, Inc. GRAHAM, ANDREW D 1742 §103 Non-Final OA 87d overdue Pending Apr 13, 2023
18132073 HYBRID PEPPER 'E20S.10382' Enza Zaden Beheer B.V. BUI, PHUONG T 1663 §112 Final Rejection 121d overdue Pending Apr 07, 2023
18030426 COMPOSITIONS AND METHODS FOR CANCER DIAGNOSIS Aoa Dx STOICA, ELLY GERALD 1647 Other Non-Final OA 14d Pending Apr 05, 2023
18192425 WIRELESS HIGH-RESOLUTION HEADPHONES Lenbrook Industries Limited SNIEZEK, ANDREW L 2693 §103 Final Rejection 16d overdue Pending Mar 29, 2023
18127887 IMAGE QUANTIFICATION SYSTEM FOR ESTIMATION OF VIRAL LOAD BASED ON DETECTION BY RAPID ANTIGEN TEST Hai Kang Life Corporation Limited DUNN, MCKENZIE A 1678 §103 Non-Final OA 23d overdue Pending Mar 29, 2023
18190487 TESTING METHOD AND KIT Spd Swiss Precision Diagnostics GmbH KUMAR, SRILAKSHMI K 1796 §103 Non-Final OA Pending Mar 27, 2023
18027003 SOLID DOSAGE FORMS OF BACTERIA Evelo Biosciences, Inc. JACKSON-TONGUE, LAKIA J 1645 §103 Non-Final OA 4d overdue Pending Mar 17, 2023
18114092 USES OF UROLITHINS Amazentis SA GANGLE, BRIAN J 1645 §102 Non-Final OA 36d overdue Pending Feb 24, 2023
18021508 LMO2 PROTEIN INHIBITORS UNIVERSITY OF OXFORD KIFLE, BRUCK 1624 §102 Non-Final OA 13d Pending Feb 15, 2023
18166868 CURE ALL FOR NUCLEIC ACID-GUIDED CELL EDITING IN E. COLI Inscripta, Inc. RYAN, DOUGLAS CHARLES 1635 Other Non-Final OA 45d overdue Pending Feb 09, 2023
18103301 SYSTEMS AND METHODS FOR CARD GAME DATA PROCESSING Rf Labs, Inc. D'AGOSTINO, PAUL ANTHONY 3715 §103 Final Rejection 223d overdue Pending Jan 30, 2023
18007189 FIRE PROTECTION SYSTEM PIPE FITTINGS Ipex Usa LLC LINFORD, JAMES ALBERT 3679 §103 Final Rejection 8d overdue Pending Jan 27, 2023
18018207 ARYL SUBSTITUTED PYRROLO-PYRIDINONES AND THERAPEUTIC USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. MARTIN, KEVIN STEPHEN 1624 §103 Non-Final OA 31d overdue Pending Jan 26, 2023
18017666 NITROGEN-CONTAINING FUSED RING DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF Jiangsu Hansoh Pharmaceutical Group Co., Ltd. TOWNSLEY, SARA ELIZABETH 1629 §103 Final Rejection 71d Pending Jan 23, 2023
18006072 SILICON-CONTAINING LIGAND COMPOUNDS Technische Universität München PACKARD, BENJAMIN J 1612 §103 Non-Final OA 36d overdue Pending Jan 19, 2023
18015906 NOVEL PEPTIDE TAG Technische Universität München MIKNIS, ZACHARY J 1658 §103 Final Rejection 31d overdue Pending Jan 12, 2023
18094643 AORTIC GRAFT ASSEMBLY Bolton Medical, Inc. RODJOM, KATHERINE MARIE 3771 §103 Final Rejection 70d overdue Pending Jan 09, 2023
18012815 HYDROGELS Commonwealth Scientific And Industrial Research Organisation STEINKE, SEAN JAMES 1619 §103 Non-Final OA 31d overdue Pending Dec 23, 2022
18011408 AMIDO COMPOUNDS Anaxis Pharma Pty Ltd JACKSON, SHAWQUIA 1626 §103 Non-Final OA 112d overdue Pending Dec 19, 2022
18011354 PRODRUGS OF MITOCHONDRIA-TARGETING OLIGOPEPTIDES Stealth BioTherapeutics Inc. KATAKAM, SUDHAKAR 1658 §103 Non-Final OA 26d Pending Dec 19, 2022
18010759 CHEMOKINE-SELECTIVE CXCR4 ECTODOMAIN-DERIVED (POLY)PEPTIDE Technische Universität München YOUNG, MICAH PAUL 1618 §112 Non-Final OA 33d Pending Dec 15, 2022
18081306 TUBULAR MEDICAL DEVICE VASCUTEK LIMITED PRESTON, REBECCA STRASZHEIM 3774 §112 Non-Final OA 10d overdue Pending Dec 14, 2022
18009826 SARS-COV-2 IMMUNODOMINANT PEPTIDES AND USES THEREOF Ahs Hospital Corp. FORD, VANESSA L 1674 Non-Final OA 27d Pending Dec 12, 2022
18009485 FLUID GEL COMPOSITIONS The University of Birmingham FAN, LYNN Y 1759 Other Non-Final OA 11d overdue Pending Dec 09, 2022
18009566 POLYSACCHARIDE COMPOSITIONS AND THERAPEUTIC GELS The University of Birmingham SHIAO, YIH-HORNG 1691 Other Non-Final OA 10d overdue Pending Dec 09, 2022
18009144 FLUID GEL COMPOSITIONS The University of Birmingham FAN, LYNN Y 1759 Other Non-Final OA 11d overdue Pending Dec 08, 2022
18007822 METHODS OF TREATING A CORONAVIRUS INFECTION The General Hospital Corporation JOHNSON, CHRISTOPHER LINDSAY 1691 §103 Non-Final OA 3d overdue Pending Dec 02, 2022
17987511 DYNAMIC ASSET TRACKING VIA LOW-ENERGY RADIO FREQUENCY DEVICES Cognosos, Inc. BILODEAU, DAVID 2648 §103 Non-Final OA 124d overdue Pending Nov 15, 2022
17923296 COMPOSITIONS COMPRISING ENZYMES AND PROBIOTICS, AND METHODS FOR PREVENTING OR TREATING MACULAR DEGENERATION Genofocus, Inc. PAGUIO FRISING, MICHELLE F 1651 Other Final Rejection 34d Pending Nov 04, 2022
18049812 VENDING MACHINE SYSTEM Navtrix Pty Ltd. CHAMPAGNE, LUNA 3627 §103 Final Rejection 22d overdue Pending Oct 26, 2022
18049832 VENDING MACHINE SYSTEM Navtrix Pty Ltd. SHAPIRO, JEFFREY ALAN 3619 §103 Non-Final OA 59d overdue Pending Oct 26, 2022
17920226 TETRAHYDROISOQUINOLINE COMPOUNDS AS NRF2 ACTIVATORS C4X Discovery Limited JOHNSON, CHRISTOPHER LINDSAY 1691 Other Non-Final OA 96d overdue Pending Oct 20, 2022
17995969 iPSC INDUCTION Roslin Technologies Limited MCCORMICK, CATHERINE LYNN 1638 §103 Final Rejection 45d overdue Pending Oct 11, 2022
17936708 COMPUTATIONAL APPROACHES TO ASSESSING CENTRAL NERVOUS SYSTEM FUNCTIONALITY USING A DIGITAL TABLET AND STYLUS Linus Health, Inc. GRANT, MICHAEL CHRISTOPHER 3715 §101 Final Rejection 72d overdue Pending Sep 29, 2022
17947312 METHODS FOR OBTAINING COMPOUNDS FROM A PLANT OR FUNGUS MATERIAL, RESPECTIVE COMPOSITIONS, AND USES THEREOF Real Isolates, LLC CHANDRAKUMAR, NIZAL S 1625 §103 Non-Final OA 1d overdue Pending Sep 19, 2022
17801055 DESIGNER PEPTIDES AND PROTEINS FOR THE DETECTION, PREVENTION AND TREATMENT OF CORONAVIRUS DISEASE, 2019 (COVID-19) United Biomedical, Inc. KINSEY WHITE, NICOLE ERIN 1672 §112 Non-Final OA 34d Pending Aug 19, 2022
17796236 DATA-DRIVEN WORKPLACE WASTE REDUCTION APPROACH INVOLVING LIVE IN-BUILDING WASTE TRACKING, LIVE DATA ANALYTICS AND EMPLOYEE ENGAGEMENT PROGRAMS Spareit, Inc. SUMMERS, KIERSTEN V 3626 §103 Non-Final OA 124d overdue Pending Jul 28, 2022
17868151 SUPPORT RING FOR VASCULAR AORTIC REPAIR AND METHODS OF USE Bolton Medical, Inc. WOZNICKI, JACQUELINE 3774 §103 Final Rejection 2d overdue Pending Jul 19, 2022
17868296 SUPPORT RING, AORTIC PROSTHESIS AND METHOD OF FORMING Bolton Medical, Inc. PELLEGRINO, BRIAN E 3799 §103 Non-Final OA 79d overdue Pending Jul 19, 2022
17781467 COMPOSITIONS AND METHODS RELATED TO MOLECULAR CONJUGATION Intocell, Inc. CHANDRAKUMAR, NIZAL S 1625 §103 Final Rejection 54d Pending Jun 01, 2022
17780819 METHODS AND COMPOSITIONS FOR CULTURING HEMOGLOBIN-DEPENDENT BACTERIA Evelo Biosciences, Inc. EIX, EMILY FAY 1653 §103 Final Rejection 52d overdue Pending May 27, 2022
17779002 METHODS OF TREATING CANCER USING DKK-1 INHIBITORS Leap Therapeutics, Inc. SULLIVAN, DENNIS JOHN 1642 Other Non-Final OA 37d overdue Pending May 23, 2022
17776276 EZETIMIBE AND CURCUMIN FOR USE IN CANCER TREATMENT University of South Africa NOTTINGHAM, KYLE GREGORY 1621 §103 Non-Final OA 44d overdue Pending May 12, 2022
17743178 PATIENT-SPECIFIC COMPUTATIONAL SIMULATION OF CORONARY ARTERY BYPASS GRAFTING BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA FERNANDEZ, KATHERINE L 3798 §103 Non-Final OA 45d overdue Pending May 12, 2022
17776068 BEAD SYSTEMS, METHODS, AND APPARATUS FOR MAGNETIC BEAD-BASED ANALYTE DETECTION Quantum Diamond Technologies Inc. MARCSISIN, ELLEN JEAN 1677 §112 Final Rejection 70d overdue Pending May 11, 2022
17723828 COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS Gnt Pharma Co., Ltd. TRAN, ERIC 1629 §103 Final Rejection 89d overdue Pending Apr 19, 2022
17768778 NON-CODING RNA PROTECTING AGAINST HEART FAILURE Medizinische Hochschule Hannover MARVICH, MARIA 1634 §112 Final Rejection 24d overdue Pending Apr 13, 2022
17767791 MULTI-DOMAIN PROTEIN VACCINE Dionis Therapeutics, Inc. MARTIN, RACHEL E 1657 §103 Non-Final OA 29d overdue Pending Apr 08, 2022
17761946 USE OF DKK-1 INHIBITORS FOR TREATING CANCER Leap Therapeutics, Inc. LU, CHENG 1642 Other Non-Final OA 11d overdue Pending Mar 18, 2022
17633254 HYBRID AMIDE DERIVATIVES OF AMPHOTERICIN B The Board Of Trustees Of The University Of Illinois GALSTER, SAMUEL LEONARD 1693 DPOther Final Rejection 61d Pending Feb 07, 2022
17632449 METHODS AND COMPOSITIONS FOR CULTURING HEMOGLOBIN-DEPENDENT BACTERIA Evelo Biosciences, Inc. SHAHNAN SHAH, KHATOL S 1645 §103 Final Rejection 43d overdue Pending Feb 02, 2022
17631169 COMPOSITE MATERIALS Anaphite Limited MCKINNON, LASHAWNDA T 1789 §103 Non-Final OA 34d Pending Jan 28, 2022
17566927 DISTRIBUTED DATA GATHERING AND RECOMMENDATION IN PHYTOTHERAPY Michael S. Clemmons NAULT, VICTOR ADELARD 2124 §112 Non-Final OA 19d overdue Pending Dec 31, 2021
17553299 LIPOSOMAL PREPARATIONS FOR NON-INVASIVE-PRENATAL OR CANCER SCREENING Seracare Life Sciences, Inc. JOHANNSEN, DIANA B 1682 §103 Final Rejection 19d Pending Dec 16, 2021
16964965 ANTIBODY-DRUG CONJUGATES THAT TARGET DLK1 AND USES THEREOF Y-Biologics, Inc. PUTTLITZ, KARL J 1646 Other Non-Final OA 219d overdue Pending Nov 30, 2021
17613341 METHODS AND COMPOSITIONS FOR ANAEROBIC BACTERIAL FERMENTATION Evelo Biosciences, Inc. MOAZZAMI, NAGHMEH NINA 1652 §103 Non-Final OA 89d overdue Pending Nov 22, 2021
17603707 THERAPEUTIC COMBINATIONS, LIQUID PHARMACEUTICAL COMPOSITIONS, KITS FOR THEIR PREPARATION, AND METHODS OF THEIR USE Prevep, Inc. DONOGHUE, BRITTNEY ERIN 1675 §103 Final Rejection 85d overdue Pending Oct 14, 2021
17602076 Enhancement of Melanocyte Migration Using ROCK Inhibitors The General Hospital Corporation MCKILLOP, JOHN CHARLES 1637 §103 Non-Final OA 2d overdue Pending Oct 07, 2021
17601383 MANUFACTURING ANTI-BCMA CAR T CELLS 2Seventy Bio, Inc. ABUZEINEH, HANAN ISAM 1633 §103 Non-Final OA 19d Pending Oct 04, 2021
17482579 TREATMENT OF ALZHEIMER'S DISEASE (AD) WITH AN ALUMINUM SALT Advantage Therapeutics, Inc. TIEN, LUCY MINYU 1612 Other Non-Final OA 21d Pending Sep 23, 2021
17441725 Methods of Treating Cancer with Chk1 Inhibitors Crt Pioneer Fund LP SZNAIDMAN, MARCOS L 1628 Other Non-Final OA 84d overdue Pending Sep 22, 2021
17464315 METHODS FOR GENERATING INDUCED PLURIPOTENT STEM CELLS VIA CELL CYCLE SYNCHRONIZATION Sapphiros Al Bio LLC ABUZEINEH, HANAN ISAM 1633 §103 Final Rejection 111d overdue Pending Sep 01, 2021
17390096 ASCAROSIDE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES Boyce Thompson Institute For Plant Research MILLER, DALE R 1693 Other Non-Final OA 49d overdue Pending Jul 30, 2021
17352493 INTEGRATED IMAGING AND MEDICAL DEVICE DELIVERY APPARATUS AND METHOD OF USE VASCUTEK LIMITED PEHLKE, CAROLYN A 3799 §103 Final Rejection 18d overdue Pending Jun 21, 2021
17296829 T Cell-Directed Anti-Cancer Vaccines Against Commensal Viruses The General Hospital Corporation SIFFORD, JEFFREY MARK 1671 §103 Non-Final OA 61d Pending May 25, 2021
17324366 OFFER SELECTION OPTIMIZATION FOR PERSONA SEGMENTS Punchh Inc. MPAMUGO, CHINYERE 3685 §101 Final Rejection 60d overdue Pending May 19, 2021
17252379 COMPOSITIONS AND METHODS FOR MODULATING MONOCYTE AND MACROPHAGE INFLAMMATORY PHENOTYPES AND IMMUNOTHERAPY USES THEREOF Verseau Therapeutics, Inc. CHASE, CAROL ANN 1646 Other Non-Final OA 112d overdue Pending Dec 15, 2020
17057432 METHODS TO IDENTIFY STRUCTURAL VARIATIONS THAT CAUSE DISEASES AND THE REGIONS TO REPAIR WITH GENE EDITING Williwaw Biosciences LLC PULLIAM, JOSEPH CONSTANTINE 1687 §103 Final Rejection 30d Pending Nov 20, 2020
17057060 CHIMERIC ANTIGEN RECEPTORS WITH MODIFIED LINKER DOMAINS AND USES THEREOF BIOSCEPTRE (AUST) PTY LTD MIDDLETON, DANAYA L 1674 §112 Non-Final OA 13d Pending Nov 19, 2020
17053422 STEM CELL-DERIVED CELL CULTURES, STEM CELL-DERIVED THREE DIMENSIONAL TISSUE PRODUCTS, AND METHODS OF MAKING AND USING THE SAME The Regents of the University of Colorado CORDAS, EMILY ANN 1632 §103 Non-Final OA 22d overdue Pending Nov 06, 2020
17089448 Diagnostic Method Amazentis SA FRITCHMAN, REBECCA M 1758 §103 Final Rejection 49d overdue Pending Nov 04, 2020
16978362 IPSC-DERIVED CELL COMPOSITIONS, AND RELATED SYSTEMS AND METHODS FOR CARTILAGE REPAIR Orig3N, Inc. MOSS, NATALIE M 1653 §103 Non-Final OA 53d overdue Pending Sep 04, 2020
16960767 SYSTEMS AND METHODS FOR DISTRIBUTING CELL THERAPIES Atara Biotherapeutics, Inc. PULLIAM, JOSEPH CONSTANTINE 1687 §103 Non-Final OA 45d overdue Pending Jul 08, 2020
16741594 ENCODING TEXTUAL DATA FOR PERSONALIZED INVENTORY MANAGEMENT Punchh Inc. RAMPHAL, LATASHA DEVI 3688 §103 Final Rejection 58d overdue Pending Jan 13, 2020
16490419 DEVICES, METHODS, AND COMPOSITIONS USEFUL IN CRYO-PRESERVATION, -STORAGE, -TRANSPORT, AND APPLICATION OF THERAPEUTIC MAMMALIAN CELLS Discgenics, Inc. ABEL, LENORA A 1799 §103 Final Rejection 15d overdue Pending Aug 30, 2019

Managing Foley Hoag, LLP (General)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month